Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial (vol 396, pg 467, 2020)

Folegatti P., Ewer K., Aley P., Angus B., Becker S., Belij-Rammerstorfer S., Bellamy D., Bibi S., Bittaye M., Clutterbuck EA., Dold C., Faust SN., Finn A., Flaxman AL., Hallis B., Heath P., Pollock KM., Ramasamy M., Robinson H., Snape M., Tarrant R., Lambe T., Gilbert SC., Pollard AJ., Grp OCOVIDVT.

Type

Journal article

Journal

LANCET

Publication Date

15/08/2020

Volume

396

Pages

466 - 466

Permalink